BioWorld
BioWorld is a daily B2B news publication covering the biopharmaceutical and medical technology industries, operated as a Clarivate subsidiary within the Cortellis life sciences intelligence portfolio and distributed via website, email, RSS, and podcast to industry executives, investors, and regulatory professionals.
- Company typePrivate
- Founded1991
- HeadquartersAtlanta, United States
- Headcount11–50
- GTM typeB2B
- OfferingDigital Commerce or Content
What BioWorld does
BioWorld is a daily B2B news publication covering the biopharmaceutical and medical technology industries, founded in 1991 and now operated as a subsidiary of Clarivate (NYSE: CLVT) within the Cortellis life sciences intelligence portfolio. The publication serves biotech and pharma executives, medical technology companies, healthcare and life sciences investors, and regulatory professionals, delivering insider intelligence on business, scientific, clinical, and regulatory developments through a website (bioworld.com), daily email newsletters posted by 9 PM EST Monday through Friday, 50+ topic-based RSS feeds, and the BioWorld Insider Podcast.
BioWorld's product surface extends beyond the flagship daily news service into specialized sub-brands (BioWorld Science for early-stage discovery and preclinical research, BioWorld Asia for Asia-Pacific coverage, BioWorld MedTech for medical device and digital health coverage), plus analytical add-ons including Data Snapshots, Index Insights, the NME Digest, and recurring Special Reports (e.g., BioWorld at 35, Biopharma M&A Scorecard, Trump administration impacts, China GLP-1 landscape). The technology stack is a conventional news content management and distribution platform; no API, developer tooling, or AI/ML features are disclosed.
The business model is subscription-based recurring revenue, with prominently featured 'Subscribe' calls-to-action on the website and enterprise-tier pricing that is not publicly disclosed. BioWorld does not file standalone financials as a Clarivate subsidiary and does not report independent revenue, headcount growth, or funding data. The publication is staffed by approximately 20 editorial, analytical, and production personnel (all using @Clarivate.com email addresses), including PhD scientists and veteran industry journalists with decades of specialist reporting experience.
BioWorld firmographics
Firmographics- Name
- BioWorld
- Legal name
- BioWorld (Clarivate)
- Website
- https://bioworld.com
- Company type
- Private
- Founded year
- 1991
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- BioWorld is a daily B2B news publication covering the biopharmaceutical and medical technology industries, operated as a Clarivate subsidiary within the Cortellis life sciences intelligence portfolio and distributed via website, email, RSS, and podcast to industry executives, investors, and regulatory professionals.
- Ownership category
- akta.pro rank
BioWorld industry classification
Industry- Product category
- Biopharmaceutical Industry News and Intelligence
- NAICS
- Publishing Industries (513)
- akta.pro primary industry
- Knowledge Management & Scientific Collaboration / Literature Intelligence (HLAGAJAN)
- akta.pro secondary industry
- Life Sciences (Biology, Ecology, Agriculture) Scholarly Publishing (EDAGAFAC)
Keywords
Where BioWorld is headquartered
LocationHeadquarters
- HQ city
- Atlanta
- HQ country
- United States
- HQ region
- North America
Markets served
BioWorld business model
Business model- GTM type
- B2B
- Offering type
- Digital Commerce or Content
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales
Revenue model
- Subscription News Service: BioWorld generates revenue through subscription services providing daily insider intelligence on biopharmaceutical and medical technology news to industry professionals. The website prominently features 'Subscribe' calls-to-action, indicating a paid subscription model for full content access.
Go-to-market motion1 record
Distribution channels4 records
Marketing channels6 records
BioWorld product offering
Product offeringCore offering
BioWorld is a daily subscription-based news and intelligence service providing insider coverage of the biopharmaceutical and medical technology industries. It delivers breaking news, analysis, regulatory updates, clinical trial results, deals and M&A, financings, and scientific developments to industry professionals via its website, email newsletters, RSS feeds, and the BioWorld Insider Podcast. The publication operates as part of Clarivate's Cortellis life sciences intelligence portfolio.
Product overview
BioWorld operates as a multi-platform news and intelligence service comprising the core BioWorld daily news service, supported by specialized sub-brands (BioWorld Science, BioWorld Asia, BioWorld MedTech), and enhanced by supplementary modules including Data Snapshots for analytics, Special Reports for thematic deep-dives, and the BioWorld Insider Podcast for audio commentary. The service provides comprehensive coverage of the biopharmaceutical and medical technology industries through multiple channels including the website, email newsletters, RSS feeds, and podcast distribution.
Differentiator
Problem solved
Functional benefit
Brands
- BioWorld Insider Podcast: One-on-one podcast with medical innovators featuring breakthrough medicines, billion-dollar deals, clinical successes and failures in biopharma.
Products and services
- BioWorld The flagship daily news service providing insider intelligence on key business, scientific, clinical, and regulatory news covering the development of innovative human therapeutics and medical technologies. Designed for biotech/pharma executives, researchers, investors, and healthcare professionals.
- BioWorld Science
Companies that use BioWorld
Customer profileSegments4 records
Ideal customer profiles4 records
BioWorld technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
BioWorld partnerships and signals
Strategic signalScale indicators1 record
Recent moves6 records
Expansion highlights5 records
BioWorld competitors and assessment
Company assessmentBroad incumbents
- Evaluate Pharma: Established provider of consensus forecasts, valuations, and commercial intelligence for the pharma and biotech industries. Comparable in serving investor and biopharma decision-makers, with deeper quantitative analytics.
- Citeline (Pharma Intelligence): Larger pharma and biotech intelligence provider (part of Informa), offering news, databases, and analytics including Pink Sheet and In Vivo. Overlaps with BioWorld's news and regulatory coverage but extends into data products and consulting.
- Pink Sheet (Citeline): Long-running regulatory and policy news service for pharma, now part of Citeline/Informa. Comparable to BioWorld's Regulatory editor coverage and overlaps on FDA/EMA policy intelligence.
Direct peers
- Genetic Engineering & Biotechnology News (GEN): Trade publication covering biotechnology R&D, drug discovery, and bioprocessing. Overlapping audience with BioWorld Science sub-brand in the discovery and preclinical science segments.
- BioSpace: Long-standing life sciences industry news and job-board platform serving biotech and pharma professionals. Overlapping audience and editorial coverage, with additional talent marketplace monetization.
- STAT News: Subscription-based life sciences news publication covering pharma, biotech, and health policy with deep investigative reporting. Comparable subscription model and overlap with biotech industry executives, investors, and researchers.
- Drug Discovery & Development: Trade publication covering early-stage drug discovery R&D, technologies, and pipelines. Directly comparable to BioWorld Science sub-brand's discovery and preclinical coverage.
- Fierce Biotech / Fierce Pharma: Trade publication covering biotech and pharma news with daily email newsletters and a subscription/marketing model. Directly comparable in audience and editorial scope, including FierceBiotech, FiercePharma, and FierceMedtech.
- Endpoints News: Daily biotech and pharma news publication with a subscription model and broad industry coverage. Closest direct competitor to BioWorld in format, audience (biotech execs and investors), and editorial positioning.
Regional players
- PharmaTimes: UK-based pharma and biotech industry news publication covering European and global pharma developments. Comparable in editorial format and audience, but with a stronger UK/European geographic tilt.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
BioWorld social profiles
Digital presenceBioWorld financial estimates
Financial estimateRevenue estimate
Valuation estimate
BioWorld leadership team
Management profileNumber of profiles
Profiles21 records
BioWorld funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
BioWorld M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about BioWorld
What does BioWorld do?
BioWorld is a daily subscription-based news and intelligence service providing insider coverage of the biopharmaceutical and medical technology industries. It delivers breaking news, analysis, regulatory updates, clinical trial results, deals and M&A, financings, and scientific developments to industry professionals via its website, email newsletters, RSS feeds, and the BioWorld Insider Podcast. The publication operates as part of Clarivate's Cortellis life sciences intelligence portfolio.
Is BioWorld a public or private company?
BioWorld is a private company. It is classified as corporate owned and is currently operating.
When was BioWorld founded?
BioWorld was founded in 1991. It employs 11 to 50 people.
Where is BioWorld based?
BioWorld is headquartered in Atlanta, United States, in the North America region.
How does BioWorld make money?
One revenue line is on record: subscription News Service.
Who are BioWorld's main competitors?
Broad incumbents on record are Evaluate Pharma, Citeline (Pharma Intelligence) and Pink Sheet (Citeline). Direct peers are Genetic Engineering & Biotechnology News (GEN), BioSpace, STAT News, Drug Discovery & Development, Fierce Biotech / Fierce Pharma and Endpoints News. PharmaTimes is listed as a regional player.
Does BioWorld have an API?
No public API is recorded for BioWorld.
What industry is BioWorld in?
BioWorld's product category is Biopharmaceutical Industry News and Intelligence. Its primary akta.pro industry code is HLAGAJAN, Knowledge Management & Scientific Collaboration / Literature Intelligence, with a secondary code of EDAGAFAC, Life Sciences (Biology, Ecology, Agriculture) Scholarly Publishing. Its NAICS code is 513.